|
December 14, 2017 0:30 - Ixifi™ (infliximab-qbtx) receives FDA approval for all eligible indications https://www.pfizer.com/news/press-release/press-release-detail/fda_approves_new_pfizer_biosimilar 2:37 - Investigational device exemption approval given to first-in-kind PAD proceedure http://www.cardiovascularbusiness.com/topics/vascular-endovascular/fda-approves-trial-test-percutaneous-procedure-pad https://www.businesswire.com/news/home/20171213005336/en/PQ-Bypass-Receives-IDE-Approval-Initiate-Study 4:37 - FDA launches new tool for sharing information that allows doctors to better manage antibiotic use; improve patient care https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm588836.htm === Brought to you by NASCENT MEDICAL Nascent Medical, LLC, has a team of over 100 PhD-/MD-level writers who can write about any medical, scientific or technical topic. They do the following types of writing, including but not limited to: -Video and virtual reality script writing -eLearning scripts -Medical education -Webinar slide creation -Manuscripts -Slidesets -Manuscripts -Press releases -Blog posts -Annual reports -Proposals -White papers -Web content -Posters -Sales training materials contact info@nascentmc.com --- New podcast coming in January 2018: Artificial Intelligence in Medicine. It will be available here: https://itunes.apple.com/us/podcast/aimedicines-podcast/id1325232000 To be on the podcast, please email info@scimedly.com |
.png)
More
Religion & Spirituality
Education
Arts and Design
Health
Fashion & Beauty
Government & Organizations
Kids & family
Music
News & Politics
Science & Medicine
Society & Culture
Sports & Recreation
TV & Film
Technology
Philosophy
Storytelling
Horror and Paranomal
True Crime
Leisure
Travel
Fiction
Crypto
Marketing
History
Comedy
Arts
Games & Hobbies
Business
Motivation